Expression of the HPV18/E6 oncoprotein induces DNA damage by Cortés Gutiérrez, Elva I. et al.
                             European Journal of Histochemistry 2017; volume 61:2773
[page 96]                                            [European Journal of Histochemistry 2017; 61:2773]
Expression of the HPV18/E6oncoprotein induces DNA damage
Elva I. Cortés Gutiérrez,1
Catalina García-Vielma,1,2
Adriana Aguilar-Lemarroy,3
Veronica Vallejo-Ruíz,4
Patricia Piña-Sánchez,5
Pablo Zapata-Benavides,2
Jaime Gosálvez6
1Genetics Department, Centro de
Investigación Biomédica del Noreste
(CIBIN), Instituto Mexicano del Seguro
Social (IMSS), Monterrey, Nuevo León,
Mexico
2Doctoral Program, Faculty of Biology,
Universidad Autónoma de Nuevo León,
Nuevo, León, Mexico
3Immunology Division, Centro de
Investigación Biomédica de Occidente
(CIBO), Instituto Mexicano del Seguro
Social (IMSS), Guadalajara, Jalisco,
Mexico
4Centro de Investigación Biomédica de
Oriente (CIBIOR), Instituto Mexicano
del Seguro Social (IMSS), Metepec,
Puebla, Mexico
5Laboratory of Molecular Oncology,
Unidad de Investigación Médica en
Enfermedades Oncológicas (UIMEO),
Instituto Mexicano del Seguro Social
(IMSS), Mexico City, Mexico 
6Unit of Genetics, Department of
Biology, Universidad Autónoma de
Madrid, Spain
Abstract
This study investigated possible varia-
tions in DNA damage in HeLa cells with
silenced expression of the HPV/E6 onco-
gene compared with HeLa cells with nor-
mal expression of the E6 oncogene using
the DNA breakage detection-fluorescence
in situ hybridization (DBD-FISH) tech-
nique and a whole human genome DNA
probe. The variable levels of DNA breaks
present were measured quantitatively using
image analysis after whole-genome DNA
hybridization. HeLa cells with silenced
expression of the HPV18/E6 oncogene
showed a significant decrease in DNA dam-
age compared with parental cells with nor-
mal expression of the E6 oncogene. These
results were confirmed by alkaline comet
assay. In conclusion, we demonstrated a
decrease in DNA damage in HeLa clones
associated with low expression of the
HPV/E6 oncogene. The significance of this
decrease regarding the HPV life cycle and
carcinogenesis requires further exploration.
Introduction
High-risk (HR) types of the human
papillomavirus (HPV) are causative agents
in virtually all cases of cervical cancer as
well as in a significant percentage of other
anogenital and oropharyngeal cancers.1 The
development of genomic instability is con-
sidered to be a key enabling hallmark in
HPV-induced carcinogenesis. HPV-associ-
ated carcinogenesis is an excellent model to
study the development of chromosomal
instability, because only two viral oncopro-
teins, E6 and E7, are consistently expressed
in cervical carcinomas.2,3 The transforming
properties of HR HPVs reside primarily in
the E6 and E7 oncogenes, and the sustained
expression of these genes appears to be
essential for the maintenance of the trans-
formed state of HPV-positive cells.4 E6 and
E7 encode small proteins that play essential
roles in the HPV life cycle.5-8 The ability of
the HR HPV E6 and E7 proteins to promote
the degradation of p53 and pRb, respective-
ly, has been suggested as a mechanism via
which HPV oncogenes induce cellular
transformation.9,10 E6 and E7 also function
to inactivate p53 and pRb.11,12 These func-
tions include association with additional
cellular proteins, activation of telomerase,
and immortalization of primary human ker-
atinocytes. Although E6 and E7 or the HPV
genome efficiently immortalize primary
human epithelial cells, they are not suffi-
cient to induce the transformation of human
cells directly.13 It is believed that the
genomic instability caused by E6 and E7
enables cells to accumulate additional
genomic aberrations that are necessary to
undergo malignant transformation.
Expression of E6 and E7 results in
DNA damage and chromosomal aberra-
tions.14 Multiple mechanisms have been
proposed to explain these observations,
such as replication stress and centrosome
amplifications;15,16 however, the mecha-
nisms underlying chromosomal instability
and malignancy remain under investigation.
DNA breakage detection-fluorescence in
situ hybridization (DBD-FISH)
This procedure allows the cell-by-cell
detection and quantification of DNA break-
age in the whole genome or within specific
DNA sequences. Cells embedded in an inert
agarose matrix on a slide are lysed to
remove their membranes and proteins, and
the remaining nucleoids are subjected to
controlled denaturation using an alkali. The
alkali transforms DNA breaks into restrict-
ed single-stranded DNA (ssDNA) motifs,
which can be detected by hybridization with
specific or whole-genome fluorescent DNA
probes.17 DBD-FISH performed using a
whole-genome probe estimates the overall
background damage in the genome. As the
number of DNA breaks increases in a target
region, more ssDNA is produced, and more
probe hybridizes, resulting in a more
intense FISH signal, which can be quanti-
fied with image analysis systems.18-20
Moreover, the alkaline treatment may break
the sugar-phosphate backbone at abasic
sites or at sites with deoxyribose damage,
thus transforming these lesions into DNA
breaks that are also converted into ssDNA.
DNA damage levels may be a conse-
quence of the torsional stress on DNA loops
associated with tight chromatin packing; it
may vary between cell types in convention-
ally conformed genomes (for example,
sperm and lymphocytes)21 and may change
if the cell is under stress, such as in the case
of gamma irradiation22 and HPV infection.23
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The aim of this study was to evaluate
DNA damage in parental HeLa cells with
normal expression of the E6 oncogene com-
pared with HeLa clones with silenced
expression of this oncogene using DBD-
FISH and the alkaline comet assay. This
information will help to understand better
the early steps of cancer development and
may improve strategies to target chromoso-
mal instability for preventive or therapeutic
purposes.
Materials and Methods
Cell culture
HeLa cell lines derived from cervical can-
cer were donated generously by the German
Cancer Research Center (DKFZ, Heidelberg,
Germany). Cells were cultured in Dulbecco’s
modified Eagle’s medium (DMEM) contain-
ing GlutaMAX™ and supplemented with
10% fetal bovine serum (FBS), 100 U/mL
penicillin, and 100 μg/ml streptomycin at 37°C
with an atmosphere of 5% CO2 and 90% rela-
tive humidity (GIBCO®, Thermo Fisher
Scientific, Inc., Waltham, MA, USA). Cells
were propagated according to the methods rec-
ommended by the suppliers.
Silencing of E6 from HPV18 in
HeLa cells
The silencing of HPV18/E6 was per-
formed using the Lentiviral shRNA vector
pLVX-shRNA1 (Cat. No. 632177, Clontech
Laboratories, Inc., Mountain View, CA,
USA). In that vector, the next sequences tar-
geting HPV18-E6 were inserted between
the BamHI and EcoRI clone sites: Forward
5 ’ - g a t c c G C TA A C A C T G G G T TA
TACAATTCAAGAGATTGTATAACCCA
GTGTTAGTTTTTTg-3’, Reverse 5’-
aattcAAAAAACTAACACTGGGTTATAC
AATCTCTTGAATTGT ATAA CCCAGT-
GTT AGCg-3’. These sequences include
the BamHI and EcoRI restriction sites for
an easier cloning. Production of viral parti-
cles was performed in the Lenti-X 293T
cells transient- transfected with the
LentiphosTM HT protocol using the Lenti-X
HT packaging system (Cat. No. 632160,
Clontech Laboratories) as recommended by
the manufacturers. Subsequently, HeLa
cells were transduced with the viral parti-
cles by incubated them for 72 h and clonal
selection was performed by selection with
puromycin.
Real Time PCR
For RNA analysis, total RNA was iso-
lated using the PureLinkTM Micro-to-Midi
Total RNA Purification System, follow by
cDNA synthesis using the SuperScriptTM III
First-Strand Synthesis System for RT-PCR
(both kits from Life Technologies
Corporation, Carlsbad, CA, USA). Real-
time PCR was carried out in a LightCycler
2.0 device using the LightCycler FastStart
DNA Master SYBR Green I kit (Roche
Applied Science, Penzberg, Germany).
Ribosomal Protein S18 (RPS18) and
Ribosomal Protein L32 (RPL32) were used
as reference genes to determine relative
expression of the target genes. The follow-
ing primers were used: 
HPV18-E6: Forward (GCGACCCTA-
CAAGCTACCTGAT); HPV18-E6 Reverse
(GCACCGCAGGCA CCTTATTA); 
RPS18: Forward (CGATGGGCGG CGG
AAAA); RPS18 (Reverse CAGTCGCTC
CAGGTCTTCA CGG);
RPL32: Forward (GCATTGACAACAGG
GTTCGTAG); RPL32 Reverse (ATT-
TAAACAGAAAACG TG CACA). 
DBD-FISH
DBD-FISH involves a protein depletion
procedure followed by treatment with an
alkaline solution, to produce ssDNA.24 To
deplete the proteins in epithelial cells, the
slides were treated with a solution of 2 M
NaCl, 0.05 M EDTA, 0.4 M Tris-base, and
1% SDS (pH 7) at 43°C for 25 min. The
slides were incubated horizontally, to avoid
chromatin dispersion.
After the initial protein removal, the
remaining nucleoids were washed in 0.9%
NaCl for 10 min, to facilitate the final pro-
tein removal. To generate ssDNA, the pro-
tein-depleted slides were incubated in an
alkaline unwinding solution containing 0.03
M NaOH and 1 M NaCl (pH 12.5) for 2.5
min at room temperature. After the sample
was neutralized with 0.4 M Tris-HCl (pH
7.5) for 5 min, the nucleoids were washed in
TBE buffer (89 mM Tris, 89 mM boric acid,
2.5 mM EDTA, pH 8.3) for 2 min. To stabi-
lize the ssDNA, the slides were dehydrated
in sequential 70%, 90%, and 100% ethanol
baths for 2 min each, and then air-dried.
A whole-genome DNA probe was pro-
duced from lymphocyte pellets using a
DNA isolation kit for mammalian blood
(Roche Diagnostics Corporation,
Indianapolis, IN, USA). An aliquot (1 µg)
of each DNA sample was labeled with
biotin-14-2′-deoxyuridine 5′-triphosphate
(dUTP), using a commercial nick-transla-
tion kit (Roche Diagnostics Corporation).
The whole-genome probe labeled with
biotin was denatured and incubated
overnight on the dried gels at room temper-
ature. The slides were then washed twice at
room temperature with 50% formamide, 
2 ×SSC (pH 7) for 5 min, and then in 2 ×
SSC (pH 7) for 3 min. The hybridized DNA
probe was detected by incubation for 30
min with FITC-labeled avidin (1:400;
Roche Diagnostics Corporation). Finally,
the slides were counterstained with 4′,6-
diamidino-2-phenylindole (DAPI) (1 μg/mL)
in Vectashield mounting medium (Vector
Laboratories, Burlingame, CA, USA). Cells
with much higher area of labeling associat-
ed to DNA replication (cells in phase-S),
and apoptotic cells were excluded of analy-
sis.20
Slides were analyzed on a digital image
analysis platform based on a Zeiss Axiophot
(Carl Zeiss, Göttingen, Germany) fluores-
cence microscope equipped with three low-
pass band filters to visualize green, red, and
blue fluorescent emissions. The images
were recorded using an Axiocam 16-bit
black-and-white CCD camera in a 12-bit
TIFF format. The integrated density (ID;
segmented area of interest × gray-level val-
ues obtained after background subtraction)
was calculated using the ImageJ 1.4.3.6.7
analysis software (National Institutes of
Health, Bethesda, MD, USA, 2012). Fifty
nuclei were examined for each experiment.
Comet assay
To confirm the results obtained with
DBD-FISH, the alkaline comet assay was
performed as described by Singh et al.25
The protein depletion, alkaline unwinding,
and alkaline treatments were performed as
described previously for the DBD-FISH
technique. The slides were placed horizon-
tally on an electrophoresis tray, which was
filled with fresh alkaline electrophoresis
solution (0.03 M NaOH, pH 13).
Electrophoresis was then conducted on ice
using an electric field of 25 V for 20 min.
All of these steps were carried out in a dark
room, to prevent interference by additional
DNA damage. After electrophoresis, the
slides were gently removed from the tray
and washed with neutralizing buffer for 5
min. The slides were washed in distilled
H2O for 5 min and then dehydrated in a
sequential series of 70%, 90%, and 100%
ethanol baths (2 min each) and were then
air-dried. Finally, the slides were stained
with propidium iodide (1 μg/mL) in
Vectashield (Vector Laboratories). Cells
treated with H2O2 at 20 μM were including
as a positive control. 
All experiments were performed in
duplicate and repeated independently at
least twice. 
One hundred cells for experiment were
scored for the distribution of DNA between
the ‘tail’ and the ‘head’; the DNA that
remained in the nucleus (head) represents
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undamaged DNA, whereas the tail contains
fragmented DNA that was able to move out
of the cell body during electrophoresis.
Statistical analysis
The Mann-Whitney nonparametric U-
test was used for evaluating differences in
fluorescence (area, intensity, and ID)
between parental HeLa cells with normal
expression of the E6 oncogene and HeLa
clones with silenced expression of this
oncogene after DBD-FISH. For the comet
assay, variance test with one criterion (one-
way ANOVA) was performed. P<0.05 was
considered significant. All analyses were
performed using IBM SPSS for Windows
20.0 (IBM Corp., Armonk, NY, USA).
Results
E6 expression in HeLa cells
To confirm E6 expression silencing,
real time PCR was performed utilizing E6
specific primers. E7 expression was also
measured, since it is known that both genes
expressed from a bicistronic mRNA. As
depicted in Figure 1, E6 expression in the
HeLa-shE6 reduces significantly when nor-
malized with RPS18 or RPL32 genes setting
HeLa parental cells as calibrator (set as 1).
A decreased expression of E7 was also
observed. 
DNA damage after of silencing
HPV18/E6 in HeLa cells
DBD-FISH performed under mild alka-
line denaturing conditions for protein
removal and DNA production led to the
detection of DNA breaks. The DNA damage
observed in parental cells was considered as
the normal-level or constitutive damage for
HeLa cells (Figure 1B). In contrast, a sig-
nificant decrease in DNA damage was
observed in cells with silenced expression
of the HPV18/E6 oncogene (Figure 2A,
Table 1). As a control treatment, H2O2 pro-
duced pronounced DNA damage, which
confirmed the accessibility of the cells to
the test chemicals and the efficient function-
ality of the technique (Figure 2C).
The presence of DNA breaks detected
by DBD-FISH was confirmed using a
comet assay performed under alkaline con-
ditions (Figure 2). The comet assay
revealed that all cells showed the presence
of a ‘comet tail’ of denatured DNA. The
length of the tails (in μm; mean ± standard
deviation) obtained for parental HeLa cells
with normal expression of the E6 oncogene
(126±7.83) (Figure 2B´) was significantly
greater (P<0.01) than that observed for cells
with silenced expression of this oncogene
(58.76±8.52; Figure 2A´). Positive control
showed higher values of DNA damage
(271.76±10.16); Figure 2C´). 
Discussion
Cervical cancer is characterized as
being a ‘disease of chromosomal instability’
because the viral oncoproteins E6 and E7
are consistently expressed in these tumors.26
This damage to DNA may lead to the muta-
tions, aberrations, and chromosomal
                             Original Paper
Table 1. Fluorescence analysis of parental HeLa cells and clones with silenced expression
of the HPV18/E6 oncogene after DBD-FISH.
                                                               Fluorescence analysis
HeLa cells          Area (X±SD)                  intensity (XD)         Integrity density (X±SD)
Parental                       56.52±40.37*°                           138.83±39.78*°                         7846.67±7327.08*°
E6 silenced                 11.93±13.31#°                             243.47±6.10#°                           2904.60±3246.86#°
Positive control         175.21±68.32#*                           471.92±84.64#*                         82685.10±115683#*
*Different to E6 silenced; °different to positive control; #different to parental.  
Figure 1. Relative expression of HPV18/E6 oncogene in parental
HeLa cells, silenced E6 (HeLa-shE6), and E7 (HeLa-shE7). The
graphs show the mean ± the standard deviation using two differ-
ent constituent genes for normalization (RPS18), and RPL32).
The value of the parent HeLa cells was used as the calibrator. 
Figure 2. DBD-FISH in parental HeLa cells (B), in cells with
silenced expression of the HPV18/E6 oncogene (A), and in a pos-
itive control treated with 0.01% H2O2 (C). Confirmation of DNA
breaks by the alkaline comet assay (A´-C´), respectively. Scale
bars: A-C) 5 µm; A´-C´) 10 µm. 
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rearrangements associated with HPV infec-
tion and cell transformation.27,28 A sufficient
number of events may ultimately allow the
occurrence of numerical and/or structural
genetic alterations that confer a growth
advantage and facilitate traversing selection
barriers.29 However, the pathogenesis of
complex chromosomal changes is unclear.
We demonstrated a decrease in DNA
damage in HeLa cells associated with a low
expression of the HPV18/E6 oncogene, as
detected by DBD-FISH and alkaline comet
assay. These data are in accordance with
previous studies that showed an association
between the expression of HPV oncogenes
and chromosomal instability.
The majority of HR HPV-associated
lesions become numerical chromosomal
aberrations, such as polyploidy and aneuso-
mias.30-33 In addition, complex cytogenetic
aberrations with chromosomal gains or
losses, as well as deletions or amplifications
of chromosome arms, are detected in HPV
immortalized cells34 and cervical can-
cers.28,35
Previously, it was thought, but not
shown directly, that the HR E6 protein
induces polyploidy in response to micro-
tubule disruption by abrogating the spindle
checkpoint, and that E6 promotes the degra-
dation of the tumor suppressor p53.36
Unaligned or lagging chromosomal materi-
al during cell division can result in defects
of the mitotic spindle checkpoint. This
checkpoint normally monitors the proper
attachment of kinetochores to spindle
microtubules and the alignment of all chro-
mosomes at the metaphase plate.37 It was
shown previously that the HPV-16 E6 and
E7 oncoproteins abrogate mitotic check-
point control.38,39
A mechanism via which E6 and E7
induce polyploidy upon DNA damage was
proposed, but not directly demonstrated,
involving cytokinesis failure as a result of
p53 inactivation and poly-like kinase 1
(Plk1) upregulation.40 pRB plays a role in
cell-cycle arrest after DNA damage41 and
inactivation of pRB itself has been implicat-
ed in genomic instability.42 This finding is
supported by previous observations that the
HR HPV E7 protein enhances the integra-
tion of DNA into chromosomes.43 Direct
interaction between a viral oncoprotein and
a mitotic spindle checkpoint protein has
been described for the HTLV-1 oncoprotein
Tax,44 but no similar interactions have been
reported for HPV E6 or E7.
A previous study showed that centro-
some-related mitotic disturbances are a
prominent finding in HPV oncoprotein-
expressing cells, and that these abnormali-
ties are caused by expression of HR HPV
E6 and E7. Interestingly, cells with HPV-16
episomes in which the E7 oncoprotein was
inactivated showed a significant reduction
of basal cells with centrosome abnormali-
ties.45
A previous study reported anaphase
bridges and micronuclei as nuclear abnor-
malities that correlate with structural chro-
mosomal changes in HPV-16 E6/E7-
expressing cells. Anaphase bridges have
been observed in various malignancies and
are believed to result from chromosomal
breaks and formation of di- or multicen-
tromeric chromosomes, thus hindering
proper segregation during mitosis. If
anaphase bridges break, chromosome frag-
ments that are able to fuse with other chro-
mosomes can be generated, and repeated
cycles of breakage-bridge-fusion can
occur.46,47 Cells with extra centrosomes in
mitosis may form multipolar spindles (also
called ‘multipolar mitosis’ or “multipolar
metaphase”). The spontaneous occurrence
of multipolar metaphases and a decrease in
the levels of p53 were observed in HPV E6
mutant-expressing cells.48 By using the
Comet assay, two independent groups have
previously reported that expression of
HPV16- E6 increase oxidative stress and
thus the amount of DNA damage. Williams
et al.49 demonstrated that expression of the
HPV16 E6* isoform increases oxidative
stress and induces oxidative DNA damage
in cell culture derived from human cervical
carcinomas (CaSki and SiHa), mouse
fibrosarcoma cells (L9299, and human
osteosarcoma (U2OS). Marullo et al.50
reported than HPV16 E6 and E7 proteins
induce a chronic oxidative stress response
via NOX2 that causes genomic instability
and increased susceptibility to DNA dam-
age in head and neck cancer cells. It has
been suggested that micronuclei may origi-
nate from acentric chromosome fragments,
either resulting from double-strand DNA
damage before cell division or after the
breakage of anaphase bridges.47 In our pre-
vious study, we demonstrated an increase of
MN in patients with cervical neoplasia and
HPV-HR infection.51 The link between
chromosomal instability and telomere ero-
sion has been well established.52 A clear
correlation between telomerase activity and
chromosomal rearrangements is found in
HPV-16 E6/E7-expressing cells.
In p53 mutant mice lacking the telom-
erase RNA component (mTerc), a strong
correlation was found between telomere
erosion and numerous complex unbalanced
translocations,53 as well as the number of
anaphase bridges.54 A correlation between
chromosomal instability and telomere ero-
sion was demonstrated in human fibroblasts
expressing HPV-16 E6.55
In addition to previous biomarkers that
were used for the evaluation of DNA dam-
age, the DBD-FISH technique is a biomark-
er that deserves special attention because of
its high sensitivity.17 The present study was
performed by analyzing the overall genome
using a whole-genome probe. However,
many different specific probes could be
hybridized, with the possibility of analyzing
chromosomal instability in HPV-HR onco-
gene-expressing cells within specific DNA
sequence areas.24
In conclusion, we demonstrated a
decrease in DNA damage in HeLa clones
associated with a low expression of the
HPV E6 oncogene. The significance of this
decrease for the HPV life cycle and carcino-
genesis requires further exploration. From a
clinical perspective, our findings provide a
better understanding of the early steps of
cancer development and may improve
strategies to target chromosomal instability
for preventive or therapeutic purposes.
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